Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 3

Sponsor Class

OTHER 56NIH 8NETWORK 3INDUSTRY 3OTHER_GOV 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 2Other neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Adenomatous Polyposis Coli 2Neoplasm Metastasis 1Colorectal Neoplasms 1

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 55Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Celecoxib × Gastrointestinal × Clear all
NCT00151476 2024-09-04

Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients

Pfizer

Terminated
68 enrolled 22 charts
Gastrointestinal

Adenomatous Polyposis Coli

NCT00585312 2021-02-21

CHIP

Pfizer

Phase 3 Terminated
106 enrolled 10 charts
Gastrointestinal

Adenomatous Polyposis Coli

NCT00037180 2008-09-29

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Pfizer

Phase 2 Terminated
212 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡